Literature DB >> 10022550

Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer.

N Chirmule1, A D Moscioni, Y Qian, R Qian, Y Chen, J M Wilson.   

Abstract

Adenovirus vectors transduce liver hepatocytes with extreme efficiency; however, transgene expression is eliminated within 2 weeks. Extinction of transgene expression has been attributed to infiltrating cytotoxic T lymphocytes (CTLs) in the liver in a process that resembles a number of human diseases, including viral and autoimmune hepatitis. In this study we investigated the role of Fas-Fas ligand interactions in killing of vector-transduced hepatocytes in vitro and in vivo. Intrahepatic lymphocytes (IHLs) isolated from livers of mice administered adenovirus vector demonstrated cytolytic activity against vector-infected primary hepatocytes. The in vitro CTL activity of the IHLs involving both CD4+ and CD8+ T cells was MHC class I restricted and could be blocked by soluble Fas-IgG. Adoptive transfer of IHLs from immune-competent mice immunized with Ad-lacZ into Ragl-deficient mice previously infused with Ad-lacZ resulted in rapid elimination of beta-galactosidase-transduced hepatocytes. Transfer of these cells into Fas-deficient mice (B6-lpr) failed to eliminate lacZ expression; likewise IHLs from immunized FasL-deficient mice (B6-gld) failed to eliminate lacZ expression in Rag1-deficient mice. Finally, in vivo administration of soluble Fas-IgG abrogated the ability of Ad-lacZ-primed IHLs to eliminate transgene expression. These studies establish an essential role for Fas-Fas ligand interactions in the mechanism of elimination of adenoviral vector-mediated transgene expression in the liver.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022550     DOI: 10.1089/10430349950019048

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  8 in total

1.  Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.

Authors:  T Zhou; J T Guo; F A Nunes; K L Molnar-Kimber; J M Wilson; C E Aldrich; J Saputelli; S Litwin; L D Condreay; C Seeger; W S Mason
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection.

Authors:  Marwan S Abougergi; Sarah J Gidner; David K Spady; Bonnie C Miller; Dwain L Thiele
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

3.  Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections.

Authors:  J T Guo; H Zhou; C Liu; C Aldrich; J Saputelli; T Whitaker; M I Barrasa; W S Mason; C Seeger
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Critical roles of TRAIL in hepatic cell death and hepatic inflammation.

Authors:  Shi-Jun Zheng; Pu Wang; Galit Tsabary; Youhai H Chen
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

5.  Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression.

Authors:  D Yin; D Tuthill; R A Mufson; Y Shi
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

Review 6.  Presentation of hepatocellular antigens.

Authors:  Arash Grakoui; Ian Nicholas Crispe
Journal:  Cell Mol Immunol       Date:  2016-02-29       Impact factor: 11.530

7.  Activation of transgene-specific T cells following lentivirus-mediated gene delivery to mouse lung.

Authors:  Maria P Limberis; Christie L Bell; Jack Heath; James M Wilson
Journal:  Mol Ther       Date:  2009-09-01       Impact factor: 11.454

8.  Malaria parasite liver stages render host hepatocytes susceptible to mitochondria-initiated apoptosis.

Authors:  A Kaushansky; P G Metzger; A N Douglass; S A Mikolajczak; V Lakshmanan; H S Kain; S Hi Kappe
Journal:  Cell Death Dis       Date:  2013-08-08       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.